BioSpace News Archive

Nourianz (istradefylline) was given the thumbs-up as an add-on treatment to levodopa/carbidopa in adults with Parkinson’s disease who experience “OFF” episodes.

It takes on average five years before the confirmatory trial is even started.

Partly because it’s an election year and partly because, well, drugs can be expensive, the topic of drug pricing is a hot-button issue.

Breztri Aerosphere is a triple combination drug of budesonide, glycopyrronium and formoterol fumarate.

Researchers at Washington University School of Medicine in St. Louis and biotech startup VaxNewMo have developed an experimental vaccine against K. pneumoniae that is effective in mice.

ASLAN Pharmaceuticals today announced that a late-breaking abstract detailing results from a phase 2 study of varlitinib in patients with advanced or metastatic biliary tract cancer in China has been accepted for oral presentation at the upcoming 2019 Chinese Society of Clinical Oncology (CSCO) in Xiamen, China on 19 September 2019.

This study aimed to determine the appropriate dose for Japanese patients treated with lurbinectedin, in monotherapy, for advanced solid tumors.

According to “people familiar with the matter,” the company and its owners, the Sackler family, are plotting out a way to end the vast number of lawsuits filed against the company over its marketing practices for OxyContin and other opioid products.

The two companies struck a strategic collaboration and option agreement to harness the power of Immatics’ T-Cell Receptor Engineered T-cell Therapy programs and aim them at solid tumors.

Not only can we humanize with storytelling; we can use stories to connect.